Chiron Real Estate Inc.
Chiron Real Estate is an internally managed real estate investment trust that primarily acquires healthcare facilities leased to physician groups and regional and national healthcare systems. Its portfolio includes medical office buildings, inpatient rehabilitation facilities, surgical hospitals and other healthcare properties, as well as active adult and other seniors residential facilities. Most healthcare properties are leased to single tenants under triple-net leases, while some have multiple tenants and gross or modified gross leases. Chiron makes money primarily from rent on its properties. It also earns fees for sourcing investments and managing the day-to-day activities of a joint venture in which it holds an interest. As of December 31, 2025, its portfolio comprised 189 buildings, and it had an interest in a joint venture that owned two healthcare facilities. Chiron is headquartered in Bethesda, Maryland.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $XRN in the last 30 days.
See all $XRN insider activity →Citizens reduced its price target for Chiron Real Estate (NYSE:XRN) to $35 from $42, citing slower lease-up at The Riviera property and lower-than-expected earnings. The company's diluted Core FFO was $0.75 per share, below Citizens' estimate but above consensus. Shares have fallen 16% since earnings, underperforming peers and the S&P 500.
Global Medical REIT (XRN) is prioritizing a $1.25B sale of outpatient medical assets, shifting focus to seniors housing. Q3 results: Nareit FFO $0.50, core FFO $0.75, outpatient medical same-store cash NOI up 1.6% YoY. Higher Treasury yields have reduced medical-property pricing by 25-50 bps.
Chiron Real Estate (XRN) reported Q3 funds from operations of $10.9M ($0.75/share) and a net loss of $8.9M ($0.67/share). Revenue was $40.3M. Funds from operations is a key metric for REITs.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning XRN (Chiron Real Estate Inc.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.
Recent XRN coverage spans earnings, insider activity and financial news.
Analyst downgrade and reduced price target suggest further downside pressure on XRN.
Earnings miss and higher yields likely pressure the REIT.
Earnings miss with a net loss may pressure the stock.
Earnings miss and lower core FFO suggest near‑term price pressure.
Governance change with limited immediate market impact.
AlphAI scores every news story that mentions XRN with an AI model for sentiment and relevance, and aggregates insider trades from Chiron Real Estate Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Citizens reduced its price target for Chiron Real Estate (NYSE:XRN) to $35 from $42, citing slower lease-up at The Riviera property and lower-than-expected earnings. The company's diluted Core FFO was $0.75 per share, below Citizens' estimate but above consensus. Shares have fallen 16% since earnings, underperforming peers and the S&P 500.
Global Medical REIT (XRN) is prioritizing a $1.25B sale of outpatient medical assets, shifting focus to seniors housing. Q3 results: Nareit FFO $0.50, core FFO $0.75, outpatient medical same-store cash NOI up 1.6% YoY. Higher Treasury yields have reduced medical-property pricing by 25-50 bps.
Chiron Real Estate (XRN) reported Q3 funds from operations of $10.9M ($0.75/share) and a net loss of $8.9M ($0.67/share). Revenue was $40.3M. Funds from operations is a key metric for REITs.
Chiron Real Estate Inc. (XRN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Chiron Real Estate Inc. Announces Third Quarter 2026 Financial Results Bethesda, MD – November 4, 2026 – (BUSINESS WIRE) – Chiron Real Estate Inc. (NYSE: XRN) (the “Company” or “Chiron”), today announced financial results for the three months ended September 30, 2026
Chiron Real Estate Inc. (XRN) appointed Charles P. Fitzgerald as Chairman of the Board, effective immediately. Founder Jeffrey Busch remains a director. The company is undergoing portfolio repositioning and focusing on senior housing.
Chiron Real Estate Inc. (XRN) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Item 2.01 Completion of Acquisition or Disposition of Assets. The Pinnacle North Bethesda On October 1, 2026, Chiron Real Estate Inc. (the " Company "), through one or more subsidiaries, closed on the acquisition of The Pinnacle North Bethesda (the “ Pinnacle ”), a senior housing
Chiron Real Estate (XRN) reported Q2 2026 net income of $63.3M ($4.78/diluted share), reversing a $0.8M loss from a year earlier. However, funds from operations (FFO) and core FFO declined. The company is focusing on senior housing, acquiring two luxury communities for $249M and reducing leverage to 39.9%. Despite some challenges in occupancy rates, management remains optimistic about long-term returns.
Whitlock Matthew Fitzsimmons (Chief Investment Officer) purchased 1,000 shares of Chiron Real Estate Inc. (XRN) at an average of $36.80 ($36.38–$37.21) across 2 trades over 2026-08-14 to 2026-08-17.
Decker Mark Okey Jr (CEO and President) purchased 6,875 shares of Chiron Real Estate Inc. (XRN) at $35.92 ($0.25M total) on 2026-08-11.
Roseth Aaron Robert (COO) purchased 13,500 shares of Chiron Real Estate Inc. (XRN) at $36.73 ($0.50M total) on 2026-08-12.
